Clinical Trial Update: Evaluation of the KIR3DL2 Marker in Flow Cytometry for Sézary Syndrome Diagnosis, Therapeutic Response and Residual Disease: a Prospective and Multicenter Study

View source ↗

Summary

Prospective multicenter study evaluating flow cytometry detection of the KIR3DL2 marker for diagnosing Sézary syndrome, assessing therapeutic response, and resi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Mycosis Fungoides
• Sézary Syndrome

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Mycosis Fungoides/Sezary Syndrome, Cutaneous T Cell Lymphoma | Status: NOT_YET_RECRUITING